Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs.

Martel CL, Mackic JB, McComb JG, Ghiso J, Zlokovic BV.

Neurosci Lett. 1996 Mar 15;206(2-3):157-60.

PMID:
8710175
3.

[Cholesterol and Alzheimer's disease].

Kálmán J, Janka Z.

Orv Hetil. 2005 Sep 11;146(37):1903-11. Review. Hungarian.

PMID:
16255374
4.

A beta A4 amyloid precursor protein gene and Alzheimer's disease.

Hendriks L, Van Broeckhoven C.

Eur J Biochem. 1996 Apr 1;237(1):6-15. Review.

5.

Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

Gosselet F, Saint-Pol J, Candela P, Fenart L.

Curr Alzheimer Res. 2013 Dec;10(10):1015-33. Review.

PMID:
24156262
6.

A beta, aging, and Alzheimer's disease: a tale, models, and hypotheses.

Chaney MO, Baudry J, Esh C, Childress J, Luehrs DC, Kokjohn TA, Roher AE.

Neurol Res. 2003 Sep;25(6):581-9. Review.

PMID:
14503011
7.

The molecular significance of amyloid beta-peptide for Alzheimer's disease.

Haass C.

Eur Arch Psychiatry Clin Neurosci. 1996;246(3):118-23. Review.

PMID:
8739395
8.

Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Deane R, Bell RD, Sagare A, Zlokovic BV.

CNS Neurol Disord Drug Targets. 2009 Mar;8(1):16-30. Review.

9.

Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Sagare AP, Bell RD, Zlokovic BV.

J Alzheimers Dis. 2013;33 Suppl 1:S87-100. Review.

10.

[Role of the blood-brain barrier in Alzheimer's disease].

Gosselet F, Candela P, Cecchelli R, Fenart L.

Med Sci (Paris). 2011 Nov;27(11):987-92. doi: 10.1051/medsci/20112711015. Epub 2011 Nov 30. Review. French.

11.

Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.

Montalto MC, Farrar G, Hehir CT.

Ann N Y Acad Sci. 2007 Feb;1097:239-58. Review.

PMID:
17413026
12.

The role of metallobiology and amyloid-β peptides in Alzheimer's disease.

Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA.

J Neurochem. 2012 Jan;120 Suppl 1:149-66. doi: 10.1111/j.1471-4159.2011.07500.x. Epub 2011 Nov 28. Review.

13.

Microvascular pathology and vascular basement membrane components in Alzheimer's disease.

Perlmutter LS.

Mol Neurobiol. 1994 Aug-Dec;9(1-3):33-40. Review.

PMID:
7888105
14.

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.

Weller RO, Boche D, Nicoll JA.

Acta Neuropathol. 2009 Jul;118(1):87-102. doi: 10.1007/s00401-009-0498-z. Epub 2009 Feb 22. Review.

PMID:
19234858
15.

[Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].

Duyckaerts C, Delaère P, He Y, Seilhean D, Hauw JJ.

Presse Med. 1994 May 14;23(18):848-54. Review. French.

PMID:
7937606
16.

Amyloid beta protein and the basis for Alzheimer's disease.

Glenner GG.

Prog Clin Biol Res. 1989;317:857-68. Review.

PMID:
2690126
17.

Molecular and cellular biology of Alzheimer amyloid.

Marotta CA, Majocha RE, Tate B.

J Mol Neurosci. 1992;3(3):111-25. Review.

PMID:
1627458
18.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Bell RD, Zlokovic BV.

Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Review.

Supplemental Content

Support Center